Association between preoperative serum Cystatin‐C levels and postsurgical oncological prognosis in patients with PRCC: A retrospective cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4731
Abstract: Cystatin‐C (Cys‐C) is a predictor of several malignancies. However, whether Cys‐C levels predict prognosis in patients with papillary renal cell carcinoma (PRCC) remains uncertain. The aim of this study was to assess the correlation between… read more here.
Keywords: association preoperative; prognosis patients; cystatin; patients prcc ... See more keywords
Efficacy of Cabozantinib for Papillary Compared With Clear-cell Renal Cell Carcinoma Following Immune Checkpoint Inhibitor Treatment
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15804
Abstract: Background: The efficacy of combined immunotherapy for papillary renal cell carcinoma (pRCC) based on prolonged progression-free survival (PFS) and overall survival in several clinical trials remains unknown. We aimed to compare the efficacy of cabozantinib… read more here.
Keywords: cell; cell carcinoma; renal cell; efficacy ... See more keywords
A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2022.989566
Abstract: Background Papillary renal cell carcinoma (pRCC) is the largest histologic subtype of non-clear-cell RCC. To date, there is no reliable nomogram to predict the prognosis of patients with pRCC after nephrectomy. We aimed to first… read more here.
Keywords: cell; cell carcinoma; renal cell; papillary renal ... See more keywords